| http://www.w3.org/ns/prov#value | - When administered before or at the same time as the carcinogen, oral I3C has been found to inhibit the development of cancer in a variety of animal models and tissues, including cancers of the mammary gland (breast) (51, 52), uterus (53), stomach (54), colon (55, 56), lung (57), and liver (58, 59).
|
